Looking for a reliable and efficient way to detect CYP2C9 genetic variants in your patients? Look no further than the Viennalab CYP2C9 PCR Kit! Our RealFast™ Assay allows for simultaneous detection of CYP2C9*2 and CYP2C9*3 variants, enabling you to quickly and accurately identify patients with impaired enzyme function.

With these genetic variants leading to high inter-individual dose response variability of certain drugs, particularly coumarin-based anticoagulants, it’s crucial to identify patients with low enzyme activity who are at risk of adverse drug reactions or therapeutic failure. By detecting PM phenotypes, you can better manage patient dosing and reduce the risk of severe bleeding during coumarin-based anticoagulation therapy with warfarin, acenocoumarol, and phenprocoumon.

Trust in the Viennalab CYP2C9 PCR Kit to provide you with reliable and accurate results, enabling you to make informed treatment decisions for your patients. Order now and experience the convenience and efficiency of RealFast™ technology!